NasdaqCM - Nasdaq Real Time Price USD

MiNK Therapeutics, Inc. (INKT)

0.9275 +0.0563 (+6.46%)
At close: April 26 at 4:00 PM EDT
0.9748 +0.05 (+5.10%)
After hours: April 26 at 7:22 PM EDT

All S.E.C. Filings

8-K : Corporate Changes & Voting Matters

March 21, 2024

10-K : Periodic Financial Reports

March 21, 2024

8-K : Corporate Changes & Voting Matters

February 29, 2024

8-K : Corporate Changes & Voting Matters

February 14, 2024

10-Q : Periodic Financial Reports

November 14, 2023

8-K : Corporate Changes & Voting Matters

November 9, 2023

8-K : Corporate Changes & Voting Matters

October 17, 2023

8-K : Corporate Changes & Voting Matters

August 10, 2023

10-Q : Periodic Financial Reports

August 10, 2023

8-K : Corporate Changes & Voting Matters

June 20, 2023

SC 13D/A : Tender Offer/Acquisition Reports

May 26, 2023

8-K : Corporate Changes & Voting Matters

May 11, 2023

10-Q : Periodic Financial Reports

May 11, 2023

SC 13D/A : Tender Offer/Acquisition Reports

May 3, 2023

DEF 14A : Proxy Statements

May 1, 2023

10-K : Periodic Financial Reports

March 24, 2023

8-K : Corporate Changes & Voting Matters

March 21, 2023

S-3 : Offering Registrations

November 3, 2022

8-K : Corporate Changes & Voting Matters

November 3, 2022

10-Q : Periodic Financial Reports

November 3, 2022

10-Q : Periodic Financial Reports

August 15, 2022

8-K : Corporate Changes & Voting Matters

August 9, 2022

8-K : Corporate Changes & Voting Matters

August 5, 2022

8-K : Corporate Changes & Voting Matters

June 14, 2022

10-Q : Periodic Financial Reports

May 13, 2022

8-K : Corporate Changes & Voting Matters

May 10, 2022

DEF 14A : Proxy Statements

April 29, 2022

10-K : Periodic Financial Reports

March 18, 2022

8-K : Corporate Changes & Voting Matters

March 8, 2022

SC 13G : Tender Offer/Acquisition Reports

February 14, 2022

Performance Overview

Return INKT S&P 500
YTD -13.32% +6.92%
1-Year -55.83% +25.26%
3-Year -- +14.06%